Baidu
map
CANCER CONTROL 润色咨询

Cancer Control

出版年份:暂无数据 年文章数:976 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:0.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2024-02-16 葵810 来自弗吉尼亚

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤;临床
    经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2024-01-02 ms5451321233 来自上海

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2024-01-02 ms448552511 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-12-28 桑晒麦拉 来自上海

    前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-11-30 ms9000001010544398 来自福建省

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:慢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-11-21 vad392838323 来自浙江省

    投稿命中率:5.0
    经验分享:这是年刊,梅斯的信息不正确

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-09-05 ms6000001587552606 来自江苏省

    偏重的研究方向:肿瘤
    经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-02-07 ms6000000857571747 来自重庆

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2023-01-22 1465389cm38暂无昵称 来自四川省

    偏重的研究方向:肿瘤
    经验分享:两个月,从投稿到接收

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:千万别投。2023年11月投稿,1月中旬初审结束,建议返修。执行编辑,伦理编辑,总编辑,一大堆表格要填。4个审稿人,总共快40个意见!!审稿意见简直无语,连基本的TNM分期也要解释,回馈的意见云里雾里,根本看不懂。这还是初审啊........才2分多的杂志,同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:这期刊编辑负责任,提出的建议都非常中肯,真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:自引率只有2.2%而且很稳定,发文量不算多,但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177820, encodeId=3b8f21e782089, content=前2年关注了这期刊,发现影响因子不算高,但每年都有增长,还不错,身边也有成功发表的,准备明年试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Thu Dec 28 16:40:14 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2172218, encodeId=5a9221e221853, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47245509838, createdName=ms9000001010544398, createdTime=Thu Nov 30 21:32:45 CST 2023, time=2023-11-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2170091, encodeId=1e0c21e00919c, content=投稿命中率:5.0<br>经验分享:这是年刊,梅斯的信息不正确, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hwG0QuDnn5xMQpTSbk5X12Hicd7PGxxlKS6975u4kHcOYL9uQ6SAZvD9eiaYicfeAGLfmIzI6obsCdp0yOoRAic10w/132, createdBy=3d1b2406281, createdName=vad392838323, createdTime=Tue Nov 21 22:25:25 CST 2023, time=2023-11-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2156209, encodeId=294121562095a, content=偏重的研究方向:肿瘤<br>经验分享:从邀请审稿人中,直接变成了review returned。这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7108512699, createdName=ms6000001587552606, createdTime=Tue Sep 05 15:19:35 CST 2023, time=2023-09-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113472, encodeId=99ea21134e200, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:肿瘤临床,返修三次接收,意见蛮多的,每次审稿回复约1-2个月,中途联系过编辑一次修改文件,编辑回复很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39565597036, createdName=ms6000000857571747, createdTime=Tue Feb 07 14:30:40 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向:肿瘤<br>经验分享:两个月,从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向:肿瘤<br>经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省)]
    2022-12-13 1871fae16em 来自江苏省

    偏重的研究方向:肿瘤
    经验分享:速度还行,三个审稿人,蛮多意见的,让我按照审稿人意见修改。但是编辑的意见是拒稿重投,时间给的也蛮久

    3

    展开3条回复
共76条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map